Add BrightSurf on Google Email

Researchers in Denmark aim to find new solutions in the fight against antibiotic resistance

A new study by Danish researchers proposes a paradigm shift in understanding antibiotic resistance, highlighting the importance of environmental factors such as temperature, oxygen levels, and pH. This new knowledge may lead to more targeted treatments and better monitoring of resistance in humans, animals, and the environment.

SourceTechnical University of Denmark·JournalTrends in Microbiology·DateSep 22, 2026

Always finish your antibiotics? Longer is better? Outdated ideas about antibiotics are common, study finds

A new study surveyed 1,475 people on their attitudes towards antibiotic course length, finding that shorter courses are as effective and safer for pneumonia, but many people prefer longer courses due to misinformation. The study suggests more nuanced communication between doctors and patients is needed.

SourceUniversity of Utah Health·JournalOpen Forum Infectious Diseases·TypeSurvey·DateAug 13, 2026

New research makes critical discovery for the global fight against antibiotic resistance

Researchers discovered a combination regimen of two β-lactam antibiotics resulted in faster and greater killing of bacteria than using each antibiotic alone. The pairing suppressed resistance to both antibiotics, offering a promising approach to optimising and personalising antibiotic regimens against life-threatening infections.

SourceMonash University·JournalThe Lancet Microbe·TypeExperimental study·DateJun 25, 2026

Machine-learning how to overcome antibiotic-resistant gonorrhea

A new study uses AI to identify promising chemical compounds that could develop into effective antibiotics against multi-drug resistant Neisseria gonorrhoeae. The approach has the potential to address the growing crisis of antimicrobial resistance in this fast-evolving pathogen.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalScience Translational Medicine·TypeComputational simulation/modeling·DateJun 17, 2026

Shiga-producing E. coli infections becoming more resistant to antibiotics, study finds

A study analyzing nearly 2,000 human infections with Shiga-producing E. coli found increasing resistance to antibiotics, particularly for tetracycline and sulfisoxazole. The researchers propose a 'One Health' approach to address the issue, focusing on antibiotic stewardship in agriculture, food safety, and environmental controls.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalFuture Microbiology·TypeData/statistical analysis·DateJun 8, 2026

Use of controversial weedkiller inadvertently selects for drug-resistant bacteria that can spread to hospitals

Scientists have found evidence that glyphosate, a widely used weedkiller, can select for drug-resistant bacteria that can thrive in agricultural areas and then spread to hospitals. The study revealed that bacterial strains from hospital infections with extreme drug resistance showed high resistance to glyphosate and its byproducts.

SourceFrontiers·JournalFrontiers in Microbiology·TypeExperimental study·DateMar 24, 2026

Why Some Bacteria Survive Antibiotics and How to Stop Them - New study reveals that bacteria can survive antibiotic treatment through two fundamentally different “shutdown modes”

Researchers identify two archetypes of growth arrest that lead to persistence: regulated and disrupted states. The former provides protection from antibiotics, while the latter is marked by vulnerabilities, particularly impaired cell membrane stability. This distinction has significant implications for developing targeted therapies.

SourceThe Hebrew University of Jerusalem·JournalScience Advances·TypeExperimental study·DateJan 2, 2026

Common painkillers linked to antibiotic resistance

Research from the University of South Australia finds that ibuprofen and paracetamol drive antibiotic resistance when used individually, but amplifying it when combined. The study also reveals that common bacteria like E. coli become highly resistant to antibiotics and multiple other medications.

SourceUniversity of South Australia·Journalnpj Antimicrobials and Resistance·TypeExperimental study·DateAug 25, 2025

AI uncovers new antibiotics in ancient microbes

Researchers at the University of Pennsylvania used AI to identify previously unknown compounds in Archaea that could fuel the development of next-generation antibiotics. The study, published in Nature Microbiology, found that 93% of the identified archaeasins demonstrated antimicrobial activity against drug-resistant bacteria.

SourceUniversity of Pennsylvania School of Engineering and Applied Science·JournalNature Microbiology·TypeExperimental study·DateAug 12, 2025

Antibiotics of the future are prone to bacterial resistance

Recent studies have found that new antibiotics are prone to rapid development of resistance, even before they are widely used. This raises concerns about the effectiveness of these treatments in the long run. To address this issue, researchers call for a shift in antibiotic development prioritizing novel modes of action and responsible...

SourceHUN-REN Szegedi Biológiai Kutatóközpont·JournalNature Microbiology·TypeExperimental study·DateJan 30, 2025

Tiny heroes and innovative technology are here to fight back against antibiotic-resistant biofilms

Researchers create silver nanoparticles infused with azithromycin that effectively break down biofilms and unveil a new sensing method to assess antimicrobial activity. The novel approach offers a promising solution against antibiotic-resistant bacteria, with potential applications in coating medical devices.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalNanoscale·TypeExperimental study·DateSep 9, 2024

Consumption of antibiotics in the community back to pre-pandemic levels in the European Union and European Economic Area

Community antibiotic consumption in the EU increased by 18.8% between 2021 and 2022, reversing a significant decline seen during the pandemic. The resurgence of infections may have contributed to the rebound, but highlights the need for continued prudent use of antibiotics.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateNov 17, 2023

Synthetic antibiotic could be effective against drug-resistant superbugs

A new antibiotic strategy has been found to defeat gram-negative bacteria like Salmonella and E. coli by interfering with the outer lipid layer of the bacteria. The compound, LPC-233, is a small molecule that works fast and is durable in animal tests, with potentially vital applications against stubborn urinary tract infections.

SourceDuke University·JournalScience Translational Medicine·TypeExperimental study·DateAug 9, 2023

Novel method to design new peptide therapeutics pioneered

Researchers developed a 'scanning and direct derivatization' method to target polymyxin, an antibiotic of last resort, for treating diseases resistant to conventional drugs. The method generated hundreds of peptide derivatives with varying effects, accelerating drug development.

SourceHokkaido University·JournalJournal of the American Chemical Society·TypeExperimental study·DateFeb 7, 2023

Hidden genes may be tapped for new antibiotics

Rice University bioscientists have developed a novel approach to control the expression of 'silent' genes in bacteria using CRISPR technology. This strategy could lead to the discovery of new antibiotics and has potential applications in antifungal and anticancer agents, as well as agriculture.

SourceRice University·JournalNucleic Acids Research·TypeExperimental study·DateJul 11, 2022

Ground-breaking bacteria-killing viruses unite with antibiotics to fight devastating antibiotic-resistant bacteria

Scientists have developed a new therapy that combines bacteriophages with antibiotics to treat antibiotic-resistant infections, specifically targeting Mycobacterium abscessus. The treatment, using the bacteriophage 'Muddy', showed significant improvement in survival rates and severity of infections when paired with rifabutin, demonstra...

SourceThe Company of Biologists·JournalDisease Models & Mechanisms·TypeExperimental study·DateSep 16, 2021